1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow LuBing: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer EGFR-TK Inhibitor, Intensity Modulated Radiation Therapy - Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Not applicable | Unknown | LuBing | 160 | 2017-10-01 | 2017-08-25 |
Carcinoma, Non-Small-Cell Lung (1)
Radiotherapy, Intensity-Modulated (1)
China (1)